Please complete this follow-up survey to help us measure the impact of our program on your practice. Please share an example of how this program influenced your practice and/or research. Do you believe your participation in this activity has… * DefinitelyVery likelyPossiblyUnlikelyNot at allNA Led to practice improvements Led to practice improvements - Definitely Led to practice improvements - Very likely Led to practice improvements - Possibly Led to practice improvements - Unlikely Led to practice improvements - Not at all Led to practice improvements - NA Led to patient benefits Led to patient benefits - Definitely Led to patient benefits - Very likely Led to patient benefits - Possibly Led to patient benefits - Unlikely Led to patient benefits - Not at all Led to patient benefits - NA How likely have you been to use the Endocrine Society practice guidelines in the management of your patients with acromegaly? * - Select -DefinitelyVery likelyPossiblyUnlikelyNot at allNA How often do you now refer or prescribe your patients with acromegaly for the following therapies or interventions? * AlwaysFrequentlySometimesRarelyNeverNA Surgical resection Surgical resection - Always Surgical resection - Frequently Surgical resection - Sometimes Surgical resection - Rarely Surgical resection - Never Surgical resection - NA Radiation therapy Radiation therapy - Always Radiation therapy - Frequently Radiation therapy - Sometimes Radiation therapy - Rarely Radiation therapy - Never Radiation therapy - NA Somatostatin analogue Somatostatin analogue - Always Somatostatin analogue - Frequently Somatostatin analogue - Sometimes Somatostatin analogue - Rarely Somatostatin analogue - Never Somatostatin analogue - NA Long-acting somatostatin analogue Long-acting somatostatin analogue - Always Long-acting somatostatin analogue - Frequently Long-acting somatostatin analogue - Sometimes Long-acting somatostatin analogue - Rarely Long-acting somatostatin analogue - Never Long-acting somatostatin analogue - NA Dopamine agonist Dopamine agonist - Always Dopamine agonist - Frequently Dopamine agonist - Sometimes Dopamine agonist - Rarely Dopamine agonist - Never Dopamine agonist - NA Growth hormone antagonist Growth hormone antagonist - Always Growth hormone antagonist - Frequently Growth hormone antagonist - Sometimes Growth hormone antagonist - Rarely Growth hormone antagonist - Never Growth hormone antagonist - NA What change(s) or improvement(s) have you made to your clinical practice following your participation in this activity? Select all that apply. * Applying current guidelines in practice Improved interpretation of biochemical assays Updated my knowledge in available therapies Earlier intervention of comorbidities Improved individualized care in medical management This activity confirmed my practice Not in practice Other... What change(s) or improvement(s) have you made to your clinical practice following your participation in this activity? Select all that apply. Other... In which area(s) do you feel your patients have benefited as a result of your participation in this activity? Select all that apply. * Earlier intervention Improved optimization of therapy Prevention of comorbid conditions Improved quality of life No patient benefit Not in practice Other... In which area(s) do you feel your patients have benefited as a result of your participation in this activity? Select all that apply. Other... Which of the following barriers have prevented you from optimally diagnosing and managing patients with acromegaly? Select all that apply. * Cost of therapy Difficulty interpreting results Difficulty identifying high-risk individuals Difficulty assessing potential benefits of therapies Late diagnosis with existing comorbidities Lacking familiarity with newer formulations Lacking familiarity with practice guidelines No barriers Other... Which of the following barriers have prevented you from optimally diagnosing and managing patients with acromegaly? Select all that apply. Other... Please share any additional feedback you have about the program. Leave this field blank
